| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.17B | +2.0% |
| Cost of Revenue | $714.3M | +7.3% |
| Gross Profit | $460.0M | -5.3% |
| R&D Expense | $4.2M | +20.0% |
| SG&A Expense | $202.0M | +12.2% |
| Operating Income | $258.0M | -15.6% |
| Pre-tax Income | $258.0M | -15.6% |
| Income Tax | $67.5M | -14.8% |
| Net Income | $190.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | +194.7% |
| Accounts Receivable | $48.1M | -45.6% |
| Inventory | $238.7M | +15.1% |
| Current Assets | $310.4M | -2.7% |
| Total Assets | $1.45B | +9.8% |
| Current Liabilities | $250.7M | -26.8% |
| Total Liabilities | $419.2M | -11.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $358.1M | +148.8% |
| Capital Expenditures | $223.6M | -3.8% |
| Investing Cash Flow | -$233.2M | +1.4% |
| Financing Cash Flow | -$122.4M | -233.1% |
| Free Cash Flow | $134.5M | +252.2% |
| -15.9% |
| EPS (Basic) | $1.78 | -14.8% |
| EPS (Diluted) | $1.78 | -14.8% |
| Stockholders' Equity |
| $1.03B |
| +21.7% |